Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pre-mRNA-processing factor 6 is a protein encoded by the PRPF6 gene, functioning as a core component of the spliceosome, specifically as part of the U4/U6-U5 tri-snRNP complex essential for pre-mRNA splicing in eukaryotic cells[1][3][4]. It serves as a bridging factor within the spliceosome, promoting interactions between small nuclear ribonucleoproteins (snRNPs), and plays a critical role in splicing regulation. PRPF6 links splicing and transcription by binding partners such as the androgen receptor, acting as a coactivator for certain steroid hormone receptors[1][4]. Mutations in PRPF6 are causative for Retinitis pigmentosa 60, underscoring its importance in RNA processing; however, PRPF6 is not a recognized therapeutic drug target, and no drugs are known to directly act on it[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pre-mRNA-processing factor 6 (PRPF6).